Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CME vs MRNA✓SelectedUSD · MRNACME vs MRNA performance historyLatest closeAs of+0.44%11/16
Stock and ETF performance explorer

CME vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+74.6%
MRNA return
-8.0%
Excess return
+82.6%
Maximum drawdown
-31.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.4%-3.6%+4.1%+0.4%
7D+4.9%-20.0%+24.9%+4.7%
30D+8.7%-1.3%+9.9%+8.7%
3M+18.9%+240.0%-221.0%+20.4%
6M+7.9%+339.0%-331.0%+9.2%
YTD+20.9%+630.0%-609.0%+21.5%
1Y+16.4%+769.1%-752.7%+16.7%
3Y+71.0%+181.2%-110.2%+74.4%
5Y+74.6%-8.1%+82.7%+78.8%
All+74.6%-8.0%+82.6%+78.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling